ENDOless
ENDOless is a technology-driven platform designed to empower women suffering from endometriosis and other chronic gynecological conditions. By providing personalized insights through symptom tracking, AI predictions, and detailed reporting, ENDOless helps users regain control over their health and well-being. The app addresses a significant gap in women's healthcare, focusing on conditions that are often overlooked and under-researched. With a mission to enhance the quality of life for women, ENDOless aims to bridge the divide between lived experiences and scientific research, ultimately striving to become the leading global platform for managing chronic pain in women.
ENDOless
ENDOless is a technology-driven platform designed to empower women suffering from endometriosis and other chronic gynecological conditions. By providing personalized insights through symptom tracking, AI predictions, and detailed reporting, ENDOless helps users regain control over their health and well-being. The app addresses a significant gap in women's healthcare, focusing on conditions that are often overlooked and under-researched. With a mission to enhance the quality of life for women, ENDOless aims to bridge the divide between lived experiences and scientific research, ultimately striving to become the leading global platform for managing chronic pain in women.
TL;DR
Focus: AI-powered women's health platform for endometriosis and chronic gynecological conditions
Product: Privacy-first mobile app (beta) with AI symptom tracking and predictive insights
Business model: Freemium consumer app, B2B employer SaaS, and Research-as-a-Service licensing
Stage: Beta; public launch planned Q1 2026
Founded: 2024 (Paris / Issy-les-Moulineaux, France)
Company Overview
Problem Domain
Endometriosis, PCOS, PMS, chronic pelvic pain, and related chronic gynecological conditions
Founded
2024
Industry
Healthtech / Women's health
Funding Track Record
€2,000,000 (target)
Seed round opened in May 2025 seeking €2 million